Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers

Virchows Archiv

Volumn 457, Issue 4, 2010, Pages 467-476

  Micello, Donata ^a   Marando, Alessandro ^b   Sahnane, Nora ^b   Riva, Cristina ^b   Capella, Carlo ^b   Sessa, Fausto ^a,b  

^a IRCCS MULTIMEDICA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

AR; ER PR negative breast cancer; HER2

Indexed keywords

ANDROGEN RECEPTOR; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ERBB2 PROTEIN, HUMAN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; BREAST TUMOR; CHEMISTRY; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 77958070002     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0964-y     Document Type: Article

References (55)

1. LM Ellis JL Wittliff MS Bryant, et al. 1989 Correlation of estrogen, progesterone, and androgen receptors in breast cancer Am J Surg 157 577 581 1:STN:280:DyaL1M3ntVyrtQ%3D%3D 10.1016/0002-9610(89)90704-6 2499206 (Pubitemid 19155592)
2. OA Lea S Kvinnsland T Thorsen, et al. 1989 Improved measurement of androgen receptors in human breast cancer Cancer Res 49 7162 7167 1:CAS:528:DyaK3cXnsVOjsw%3D%3D 2582456
3. N Kimura A Mizokami T Oonuma, et al. 1993 Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissue J Histochem Cytochem 41 671 678 1:CAS:528:DyaK3sXisVOqtLY%3D 8468448
4. RE Hall JO Aspinall DJ Horsfall, et al. 1996 Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer Br J Cancer 74 1175 1180 1:STN:280:DyaK2s%2FjslOksQ%3D%3D 8883401
5. V Kuenen-Boumeester TH Van Der Kwast CC Claassen, et al. 1996 The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters Eur J Cancer 32A 1560 1565 1:STN:280:DyaK2s%2FmslOksg%3D%3D 10.1016/0959-8049(96)00112-8 8911118 (Pubitemid 26279124)
6. I Bièche B Parfait S Tozlu, et al. 2001 Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene Carcinogenesis 22 1521 1526 10.1093/carcin/22.9.1521 11532875
7. M Brys M Wojcik H Romanowicz-Makowska, et al. 2002 Androgen receptor status in female breast cancer: RT-PCR and Western blot studies J Cancer Res Clin Oncol 128 85 90 1:CAS:528:DC%2BD38XjvFCksQ%3D%3D 10.1007/s004320100294 11862478 (Pubitemid 34117830)
8. SN Agoff PE Swanson H Linden, et al. 2003 Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical and prognostic associations Am J Clin Pathol 120 725 731 1:CAS:528: DC%2BD3sXpsVOnsL8%3D 10.1309/42F00D0DJD0J5EDT 14608899
9. F Moinfar M Okcu O Tsybrovskyy, et al. 2003 Androgen receptors frequently are expressed in breast carcinomas. Potential relevance to new therapeutic strategies Cancer 98 703 711 1:CAS:528:DC%2BD3sXntVWgtbc%3D 10.1002/cncr.11532 12910513 (Pubitemid 36959265)
10. C Riva E Dainese G Caprara, et al. 2005 Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma Virchows Arch 447 695 700 1:CAS:528:DC%2BD2MXhtFKqt73L 10.1007/s00428-005-0003-6 16075292 (Pubitemid 41571184)
11. D Narita M Raica C Suciu, et al. 2006 Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer Folia Histochem Cytobiol 44 165 172 16977795 (Pubitemid 44131983)
12. V Kuenen-Boumeester TH Van Der Kwast WLJ Van Putten, et al. 1992 Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer Int J Cancer 52 581 584 1:STN:280:DyaK3s%2FhsVeksA%3D%3D 10.1002/ijc.2910520415 1399140
13. JA Soreide OA Lea JE Varhaug, et al. 1992 Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlation to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment Eur J Surg Oncol 18 112 118 1:STN:280:DyaK383lvVGmtg%3D%3D 1582503
14. JJ Isola 1993 Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors J Pathol 170 31 35 1:STN:280:DyaK3szhs1ansg%3D%3D 10.1002/path.1711700106 8100853
15. EA Rakha ME El-Sayed AR Green, et al. 2007 Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression Histopathology 50 434 438 1:STN:280:DC%2BD2s3ktVCqtQ%3D%3D 10.1111/j.1365-2559.2007.02638.x 17448018 (Pubitemid 46328193)
16. IB Bayer-Garner B Smoller 2000 Androgen receptors: a marker of increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site Mod Pathol 13 119 122 1:STN:280:DC%2BD3c7mtVensg%3D%3D 10.1038/modpathol. 3880021 10697267
17. RM Bryan RJ Mercer RC Bennett, et al. 1984 Androgen receptors in breast cancer Cancer 54 2436 2440 1:STN:280:DyaL2M%2FkvVGlug%3D%3D 10.1002/1097- 0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H 6498736 (Pubitemid 15223385)
18. W Schippinger P Regitnig N Dandachi, et al. 2006 Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer Virchows Arch 449 24 30 1:CAS:528:DC%2BD28Xmtlais7g%3D 10.1007/s00428-006-0213-6 16628414 (Pubitemid 43988362)
19. CM Perou T Sørlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 1:CAS:528:DC%2BD3cXmt1CnsLw%3D 10.1038/35021093 10963602
20. T Sørlie CM Perou R Tibshirani, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869 10874 10.1073/pnas.191367098 11553815 (Pubitemid 32878711)
21. T Sørlie R Tibshirani J Parker, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 8418 8423 10.1073/pnas.0932692100 12829800 (Pubitemid 36842560)
22. A El-Rehim G Ball SE Pinder, et al. 2005 High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses Int J Cancer 116 340 350 10.1002/ijc.21004 (Pubitemid 40993329)
23. MD Mattie CC Benz J Bowers, et al. 2006 Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies Mol Cancer 5 24 10.1186/1476-4598-5-24 16784538 (Pubitemid 44376886)
24. P Farmer H Bonnefoi V Becette, et al. 2005 Identification of molecular apocrine breast tumours by microarray analysis Oncogene 24 4660 4671 1:CAS:528:DC%2BD2MXlvVGhsLc%3D 10.1038/sj.onc.1208561 15897907 (Pubitemid 41032603)
25. N Quenel J Wafflart F Bonichon, et al. 1995 The prognostic value of c-erbB2 in primary breast carcinomas: a study on 942 cases Breast Cancer Res Treat 35 283 291 1:STN:280:DyaK28%2FntVaruw%3D%3D 10.1007/BF00665980 7579499
26. AL Hubbard CP Doris AM Thompson, et al. 1994 Critical determination of the frequency of c-erbB-2 amplification in breast cancer Br J Cancer 70 434 439 1:STN:280:DyaK2czmtF2huw%3D%3D 7915911
27. JS Ross JA Fletcher 1999 HER-2/neu (c-erb-B2) gene and protein in breast cancer Am J Clin Pathol 112 S53 S67 1:CAS:528:DyaK1MXktlCjt7k%3D 10396301
28. AS Doane M Danso P Lal, et al. 2006 An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen Oncogene 25 3994 4008 1:CAS:528:DC%2BD28Xmtlahs7o%3D 10.1038/sj.onc.1209415 16491124 (Pubitemid 43990755)
29. B Liegl LC Horn F Moinfar 2005 Androgen receptors are frequently expressed in mammary and extramammary Paget's disease Mod Pathol 18 1283 1288 1:CAS:528:DC%2BD2MXhtVWiu7fM 10.1038/modpathol.3800437 15920545 (Pubitemid 41348646)
30. A Naderi L Hughes-Davies 2008 A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer Neoplasia 10 542 548 1:CAS:528:DC%2BD1cXoslWgtb4%3D 18516291
31. EA Rakha ME El-Sayed AR Green, et al. 2007 Prognostic markers in triple-negative breast cancer Cancer 109 25 32 1:CAS:528:DC%2BD2sXhtVKrtLY%3D 10.1002/cncr.22381 17146782 (Pubitemid 46120191)
32. Greene FL, Page DL, Fleming ID et al (2002) The AJCC cancer staging manual, 6th edn. Springer, New York, pp 257-281
33. Tavassoli FA, Devilee P (2003) Pathology & genetics tumours of the breast and female genital organs. WHO, Albany
34. CW Elston IO Ellis 2002 Pathological prognostic factors in breast cancer I The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 41 3 151 153 1:STN:280: DC%2BD38nkslWrtg%3D%3D 10.1046/j.1365-2559.2002.14691.x 12405945 Histopathology 1991;403-410 (Pubitemid 41713015)
35. M Laakso N Loman A Borg J Isola, et al. 2005 Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors Mod Pathol 18 1321 1328 1:CAS:528:DC%2BD2MXhtVWiu7fI 10.1038/modpathol.3800456 15990899 (Pubitemid 41348650)
36. M Laakso M Tanner J Nilsson, et al. 2006 Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer Clin Cancer Res 12 4185 4191 1:CAS:528:DC%2BD28XntFSms7o%3D 10.1158/1078-0432.CCR-06-0353 16857790
37. Z Nahleh 2008 Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory Future Oncol 4 15 21 1:CAS:528:DC%2BD1cXhslehs7o%3D 10.2217/14796694.4.1.15 18240997 (Pubitemid 351372603)
38. R Zaucha K Sosinska-Mielcarek J Jassem 2004 Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with Medroxyprogesterone acetate Breast 13 321 324 1:STN:280:DC%2BD2cvhvVKmtw%3D%3D 10.1016/j.breast.2004.05.003 15325667 (Pubitemid 39172733)
39. S Otani N Toyota K Nozaka, et al. 2004 Successful combination therapy with 5′-DFUR and MPA for breast cancer with spinal and vertebral metastases Gan To Kagaku Ryoho 31 2151 2153 15628761
40. C Focan M Beauduin F Majos, et al. 2004 High-dose oral medroxyprogesterone acetate or tamoxifen as adjuvant hormone therapy for node-negative early-stage breast cancer: randomized trial with 7-year update Clin Breast Cancer 5 136 141 1:CAS:528:DC%2BD2cXmslWmu74%3D 10.3816/CBC.2004.n. 018 15245618
41. R Scawn S Shousha 2002 Morphologic spectrum of estrogen receptor-negative breast carcinoma Arch Pathol Lab Med 126 325 330 11860308
42. TC Putti DM El-Rehim EA Rakha, et al. 2005 Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis Mod Pathol 18 26 35 1:CAS:528:DC%2BD2MXivVWj 10.1038/modpathol.3800255 15332092 (Pubitemid 40128091)
43. DC Allred JM Harvey M Berardo, et al. 1998 Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 155 168 1:STN:280:DyaK1c7mtlaitg%3D%3D 9504686
44. S Yeh HK Lin HY Kang, et al. 1999 From HER/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells Proc Natl Acad Sci U S A 96 5458 5463 1:CAS:528:DyaK1MXjtFCnsLY%3D 10.1073/pnas.96.10.5458 10318905 (Pubitemid 29234639)
45. TC Meng MS Lee MF Lin 2000 Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells Oncogene 19 2664 2677 1:CAS:528: DC%2BD3cXktFalt7w%3D 10.1038/sj.onc.1203576 10851066
46. Y Liu S Majumder W McCall, et al. 2005 Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer Cancer Res 65 3404 3409 1:CAS:528:DC%2BD2MXjt1yrsb4%3D 15833875
47. Z Guo B Dai T Jiang, et al. 2006 Regulation of androgen receptor activity by tyrosine phosphorylation Cancer Cell 66 10 309 319 10.1016/j.ccr.2006.08.021 (Pubitemid 44512189)
48. IK Mellinghoff I Vivanco A Kwon, et al. 2004 HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability Cancer Cell 6 517 527 1:CAS:528:DC%2BD2cXhtVGlurjI 10.1016/j.ccr.2004.09.031 15542435 (Pubitemid 39469987)
49. D Shao MA Lazar 1999 Modulating nuclear receptor function: may the phos be with you J Clin Invest 103 1617 1618 1:CAS:528:DyaK1MXktVCms7o%3D 10.1172/JCI7421 10377165
50. LA Niemeier DJ Dabbs S Beriwal, et al. 2010 Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation Mod Pathol 23 205 212 1:CAS:528:DC%2BC3cXhsVyjtbg%3D 10.1038/modpathol.2009.159 19898421
51. S Park J Koo HS Park, et al. 2010 Expression of androgen receptors in primary breast cancer Ann Oncol 21 488 492 1:STN:280:DC%2BC3c7isV2hsg%3D%3D 10.1093/annonc/mdp510 19887463
52. C Jones AV Nonni L Fulford, et al. 2001 CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation Br J Cancer 85 422 427 1:STN:280:DC%2BD3MvktFCmtA%3D%3D 10.1054/bjoc.2001.1869 11487275 (Pubitemid 32747712)
53. TO Nielsen FD Hsu K Jensen, et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 1:CAS:528:DC%2BD2cXmvFSlt7k%3D 10.1158/1078-0432.CCR-04- 0220 15328174 (Pubitemid 39100473)
54. EA Rakha TC Putti DM Abd El-Rehim, et al. 2006 Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation J Pathol 208 495 506 1:CAS:528:DC%2BD28XislCqt78%3D 10.1002/path.1916 16429394 (Pubitemid 43329336)
55. RE Moe BO Anderson 2007 Androgens and androgen receptors: a clinically neglected sector in breast cancer biology J Surg Ong 95 437 439 10.1002/jso.20722 (Pubitemid 46709384)